Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,426 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel Osteogenic Behaviors around Hydrophilic and Radical-Free 4-META/MMA-TBB: Implications of an Osseointegrating Bone Cement.
Sugita Y, Okubo T, Saita M, Ishijima M, Torii Y, Tanaka M, Iwasaki C, Sekiya T, Tabuchi M, Mohammadzadeh Rezaei N, Taniyama T, Sato N, Saruta J, Hasegawa M, Hirota M, Park W, Lee MC, Maeda H, Ogawa T. Sugita Y, et al. Among authors: okubo t. Int J Mol Sci. 2020 Mar 31;21(7):2405. doi: 10.3390/ijms21072405. Int J Mol Sci. 2020. PMID: 32244335 Free PMC article.
Transplantation of Mature Adipocyte-Derived Dedifferentiated Fat Cells Facilitates Periodontal Tissue Regeneration of Class II Furcation Defects in Miniature Pigs.
Akita D, Kazama T, Tsukimura N, Taniguchi Y, Takahashi R, Arai Y, Tsurumachi-Iwasaki N, Yasuda H, Okubo T, Kano K, Matsumoto T, Honda M. Akita D, et al. Among authors: okubo t. Materials (Basel). 2022 Feb 10;15(4):1311. doi: 10.3390/ma15041311. Materials (Basel). 2022. PMID: 35207844 Free PMC article.
Outcomes of patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab in real-world clinical practice who met or did not meet the inclusion criteria for the phase 3 IMbrave150 trial.
Tada T, Kumada T, Hiraoka A, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Nishikawa H, Tsuji K, Ishikawa T, Tajiri K, Koshiyama Y, Toyoda H, Ogawa C, Hatanaka T, Kakizaki S, Kawata K, Ohama H, Tada F, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Nishimura T, Imai M, Kosaka H, Naganuma A, Matono T, Aoki T, Kuroda H, Yata Y, Koizumi Y, Nakamura S, Enomoto H, Kaibori M, Hiasa Y, Kudo M; Real‐life Practice Experts for HCC (RELPEC) Study Group; Hepatocellular Carcinoma Experts from 48 clinics in Japan (HCC 48) Group. Tada T, et al. Among authors: okubo t. Aliment Pharmacol Ther. 2024 May 8. doi: 10.1111/apt.18037. Online ahead of print. Aliment Pharmacol Ther. 2024. PMID: 38716823
1,426 results